top of page
Search

Ozempic and Heart Disease

  • Writer: DrShivago
    DrShivago
  • Jul 26, 2024
  • 1 min read

Y POINTS

  • The U.K.’s health regulator on Tuesday approved the use of Novo Nordisk’s #Wegovy weight loss drug to reduce the risk of #overweight and #obese adults suffering from serious #heartproblems or #strokes.

  • It follows similar label expansion by the U.S. Food and Drug Administration in March.

 
 
 

Recent Posts

See All
Oral GLP

Oral GLP-1 drugs are likely to expand the market massively The more disruptive development may actually be oral agents. Many patients are willing to take a pill but reluctant to self-inject indefinite

 
 
 
Novi and Eli Lilly in fierce competition

Novo Nordisk launches multi-month subscriptions for Wegovy obesity drugs as it tries to catch up with Eli Lilly PUBLISHED TUE, MAR 31 20267:39 AM EDTUPDATED TUE, MAR 31 20262:10 PM EDT Annika Kim Cons

 
 
 

Comments

bottom of page